Zenghui Hao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Zenghui Hao has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Ting Yao
Department of Pediatric Surgery, The Sixth Affiliated Hospital of Harbin Medical University, Harbin, People’s Republic of China
2 shared publications - Wei Fan
Department of Pediatric Surgery, The Sixth Affiliated Hospital of Harbin Medical University, Harbin, China
2 shared publications - Zhilin Xu
Department of Pediatric Surgery, The Sixth Affiliated Hospital of Harbin Medical University, Harbin, People’s Republic of China
2 shared publications - Chao Li
Department of Neurology, The First Hospital of Jilin University, Changchun, 130021, China
1 shared publication - Jinbao Han
Department of Emergency Center, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China, ccmu.edu.cn
1 shared publication - Long Wang1 shared publication
Latest Publications
- Open Access
- 3 April 2026
- Published by Springer Nature in Cell & Bioscience
- Vol. 16 (1)
Gordonibacter-associated regulatory T cell dysfunction and S100A11-mediated neural impairment in Hirschsprung’s disease: a microbiota-immune-neural axis
Hirschsprung’s disease (HSCR) is a congenital disorder characterized by intestinal aganglionosis. Despite evidence linking gut microbiota and immune
- 3 April 2026
- Published by Springer Nature in Cell & Bioscience
- Vol. 16 (1)
Open AccessGordonibacter-associated regulatory T cell dysfunction and S100A11-mediated neural impairment in Hirschsprung’s disease: a microbiota-immune-neural axis
Hirschsprung’s disease (HSCR) is a congenital disorder characterized by intestinal aganglionosis. Despite evidence linking gut microbiota and immune
- Open Access
- 7 January 2026
- Published by Wiley in Mediators of Inflammation
- Vol. 2026 (1)
ALAS2 Prevents Neonatal Necrotizing Enterocolitis by Improving Ferroptosis in Intestinal Epithelial Cells Through Inhibition of Oxidative Stress
Neonatal necrotizing enterocolitis (NEC) is an intestinal disease that occurs in the neonatal period. The purpose of this study was to investigate the role of 5′‐aminolevulinate synthase 2 (ALAS2) in NEC‐induced intestinal injury. In a neonatal mouse, NEC model was induced by high‐osmolarity formula and hypoxia‐cold stress, and ALAS2 expression was significantly downregulated in ileal tissues ( p < 0.01), coinciding with elevated oxidative stress (increased Fe 2+ /malondialdehyde [MDA] and decreased superoxide dismutase [SOD]), inflammation (increased TNF‐α/interferon‐gamma [IFN‐γ]), and ferroptosis activation (increased acyl‐CoA synthetase long‐chain family member 4 [ACSL4] and decreased ferritin heavy chain 1 [FTH1] with mitochondrial shrinkage). In vitro, tumor necrosis factor‐alpha (TNF‐α)/IFN‐γ‐treated intestinal epithelial cell (IEC) exhibited progressive ALAS2 suppression and increased necrosis. Crucially, lentivirus‐mediated ALAS2 overexpression reversed these effects, reducing cell necrosis by 22% while suppressing ferroptosis markers (Fe 2+ accumulation, lipid reactive oxygen species [ROS], and mitochondrial depolarization) and oxidative damage (decreased MDA and restored glutathione [GSH]/catalase [CAT]/SOD). Untargeted metabolomics further revealed ALAS2‐mediated modulation of nutrient metabolism and redox pathways. Collectively, ALAS2 ameliorates NEC by blocking oxidative stress‐driven ferroptosis in IECs, proposing a novel therapeutic target.
- 7 January 2026
- Published by Wiley in Mediators of Inflammation
- Vol. 2026 (1)
Open AccessALAS2 Prevents Neonatal Necrotizing Enterocolitis by Improving Ferroptosis in Intestinal Epithelial Cells Through Inhibition of Oxidative Stress
Neonatal necrotizing enterocolitis (NEC) is an intestinal disease that occurs in the neonatal period. The purpose of this study was to investigate the role of 5′‐aminolevulinate synthase 2 (ALAS2) in NEC‐induced intestinal injury. In a neonatal mouse, NEC model was induced by high‐osmolarity formula and hypoxia‐cold stress, and ALAS2 expression was significantly downregulated in ileal tissues ( p < 0.01), coinciding with elevated oxidative stress (increased Fe 2+ /malondialdehyde [MDA] and decreased superoxide dismutase [SOD]), inflammation (increased TNF‐α/interferon‐gamma [IFN‐γ]), and ferroptosis activation (increased acyl‐CoA synthetase long‐chain family member 4 [ACSL4] and decreased ferritin heavy chain 1 [FTH1] with mitochondrial shrinkage). In vitro, tumor necrosis factor‐alpha (TNF‐α)/IFN‐γ‐treated intestinal epithelial cell (IEC) exhibited progressive ALAS2 suppression and increased necrosis. Crucially, lentivirus‐mediated ALAS2 overexpression reversed these effects, reducing cell necrosis by 22% while suppressing ferroptosis markers (Fe 2+ accumulation, lipid reactive oxygen species [ROS], and mitochondrial depolarization) and oxidative damage (decreased MDA and restored glutathione [GSH]/catalase [CAT]/SOD). Untargeted metabolomics further revealed ALAS2‐mediated modulation of nutrient metabolism and redox pathways. Collectively, ALAS2 ameliorates NEC by blocking oxidative stress‐driven ferroptosis in IECs, proposing a novel therapeutic target.
- Open Access
- 1 October 2018
- Published by Elsevier in Journal of Pediatric Surgery Case Reports
- Vol. 37, 70-73
ALPPS for hepatic mesenchymal hamartoma in an infant
- 1 October 2018
- Published by Elsevier in Journal of Pediatric Surgery Case Reports
- Vol. 37, 70-73
Open AccessALPPS for hepatic mesenchymal hamartoma in an infant